Glenmark recieves US FDA approval for Ranitidine tablets

New Delhi, Nov 21 (UNI) Glenmark Pharmaceuticals Ltd today said it has received approval from the United States Food and Drug Administration (USFDA) for distribution and marketing of Ranitidine tablets in the US market.

Ranitidine tablets are used for treating duodenal and gastric ulcers and erosive esophagitis, the company said.

They also said the drug would be available in tablet form in the strengths of 150 mg base and 300 mg base, respectively UNI AK SBC ND1302